Mito Biopharm, LLC is a biopharmaceutical company based in Piscataway, NJ, specializing in the research and development of therapeutic solutions for non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes. With a focus on addressing the continuum of NAFLD, from simple fat accumulation in the liver to more severe conditions like non-alcoholic steatohepatitis (NASH), Mito Biopharm aims to provide innovative treatments to prevent the progression of these diseases.
Driven by cutting-edge technology and a dedicated team of experts, Mito Biopharm is committed to advancing drug discovery and developing a robust pipeline of potential therapies. With a strong emphasis on intellectual property, the company strives to make significant contributions to the field of biopharmaceuticals and improve the lives of patients affected by NAFLD and type 2 diabetes.
Generated from the website